MOR — Morphosys AG Cashflow Statement
0.000.00%
Last trade - 00:00- €2.55bn
- €2.31bn
- €238.28m
Annual cashflow statement for Morphosys AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -103 | 97.9 | -514 | -151 | -190 |
| Depreciation | |||||
| Non-Cash Items | -2.07 | -83.5 | 201 | -174 | -126 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 17.8 | 11.8 | -178 | -51.9 | 9.83 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -81.1 | 34.5 | -481 | -367 | -296 |
| Capital Expenditures | -3.67 | -49.3 | -26.2 | -15.2 | -2.87 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 83.1 | -830 | -805 | 360 | 18.2 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 79.5 | -880 | -831 | 345 | 15.4 |
| Financing Cash Flow Items | -1.01 | 509 | 1,241 | 315 | -11.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.353 | 907 | 1,323 | 311 | 43 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.15 | 65.5 | 13.5 | 279 | -244 |